VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) Stock Price, Forecast & Analysis
Canada - TSX Venture Exchange - TSX-V:VPT - CA92281P2008 - Common Stock
VPT.CA Key Statistics, Chart & Performance
The current stock price of VPT.CA is 0.12 CAD. In the past month the price increased by 41.18%. In the past year, price increased by 20%.
VPT.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PRN.CA | PROFOUND MEDICAL CORP | N/A | 309.45M | ||
| MIR.CA | MEDMIRA INC | N/A | 56.87M | ||
| PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 48.44M | ||
| TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 39.64M | ||
| CNVI.CA | CONAVI MEDICAL CORP | N/A | 35.69M | ||
| ASG.CA | AURORA SPINE CORP | N/A | 19.69M | ||
| NSCI.CA | NANALYSIS SCIENTIFIC CORP | N/A | 19.10M | ||
| MDX.CA | MEDX HEALTH CORP | N/A | 18.04M | ||
| THRM.CA | THERMA BRIGHT INC | N/A | 2.84M | ||
| VER-H.CA | VERISANTE TECHNOLOGY INC | N/A | 659.10K | ||
| VVTM.CA | VVT MED INC | N/A | 19.38M |
Related stock screener links
About VPT.CA
Company Profile
VentriPoint Diagnostics Ltd. is a medical device company, which engages in the development and commercialization of diagnostic tools that monitor patients with heart disease. The company is headquartered in Toronto, Ontario. The company went IPO on 2005-11-09. The company is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. The company develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. The company provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. The company has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.
Company Info
VENTRIPOINT DIAGNOSTICS LTD
18 Hook Ave, Unit 101
TORONTO ONTARIO M2N 5Y7 CA
CEO: George Adams
Employees: 0
Phone: 14168484156
VENTRIPOINT DIAGNOSTICS LTD / VPT.CA FAQ
What does VENTRIPOINT DIAGNOSTICS LTD do?
VentriPoint Diagnostics Ltd. is a medical device company, which engages in the development and commercialization of diagnostic tools that monitor patients with heart disease. The company is headquartered in Toronto, Ontario. The company went IPO on 2005-11-09. The company is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. The company develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. The company provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. The company has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.
Can you provide the latest stock price for VENTRIPOINT DIAGNOSTICS LTD?
The current stock price of VPT.CA is 0.12 CAD. The price decreased by -4% in the last trading session.
Does VPT stock pay dividends?
VPT.CA does not pay a dividend.
What is the ChartMill rating of VENTRIPOINT DIAGNOSTICS LTD stock?
VPT.CA has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What sector and industry does VENTRIPOINT DIAGNOSTICS LTD belong to?
VENTRIPOINT DIAGNOSTICS LTD (VPT.CA) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Should I buy VPT stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on VPT.CA.
VPT.CA Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to VPT.CA. When comparing the yearly performance of all stocks, VPT.CA turns out to be only a medium performer in the overall market: it outperformed 66.29% of all stocks.
VPT.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to VPT.CA. VPT.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
VPT.CA Financial Highlights
Over the last trailing twelve months VPT.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS increased by 23.15% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1076.66% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |